«Nasal Lavage Fluid

Below is an extended Nasal Lavage Fluid patents listing. Click here to return to the Nasal Lavage Fluid main in depth entry.

Patents :
US Patent No.	Title
7410784	Quantitation of enzyme activity using planar waveguides
6048536	Vaccine compositions
6022969	Compositions and methods for treating mast-cell mediated conditions
5972698	Tryptase inhibitor
5876727	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
5840307	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
5827512	Method for the treatment of bronchial asthma and like hypersensitivity diseases by administration of anionic polymers
5773003	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
5760184	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
5743256	Nostril closure means
5631267	Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics
5525623	Compositions and methods for the treatment of immunomediated inflammatory disorders
5510339	Method for the treatment of bronchial asthma by administration of topical anesthetics
6054127	Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
6211228	Compositions and methods for treating mast-cell mediated conditions
6361779	Transferrin receptor genes
7323183	Vaccine compositions including chitosan for intranasal administration and use thereof
7118749	Transferrin receptor genes
6987168	Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites
6849447	Protective recombinant Haemophilus influenzae high molecular weight proteins
6716819	Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
6617312	Vasoactive amine binding molecules
6562854	Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
6436924	Antihistamine leukotriene combinations
6432669	Protective recombinant Haemophilus influenzae high molecular weight proteins
6416955	Eosinophil degranulating conditions
6391318	Vaccine compositions including chitosan for intranasal administration and use thereof
6365575	Gene delivery and expression in areas inaccessible to direct protein delivery
5498410	Method for the treatment of eosinophil-associated conditions with anionic polymers

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.